Cyrus Chowdhury, Vice President of the Global Market Access practice at Insight Strategy Advisors, will be speaking on several topics at the upcoming ‘Pharmaceutical Pricing and Reimbursement Summit’ this November 9th-10th in London, UK.

Visiongain.com – Pharmaceutical Pricing and Reimbursement Summit

Mr. Chowdhury will speak about market access issues in Russia and Central / Eastern Europe, providing a review of the latest developments in Russian pharmaceutical industry policies and their impact on multinational pharmaceutical companies looking to do business in the evolving BRIC. He will also add perspective on surrounding area markets, including Austria, Romania and Bulgaria.

Another session led by Mr. Chowdhury will address the Chinese pharmaceutical industry and keys to success n this emerging market. In this session Mr. Chowdhury will offer insight to the coming arrival of the next installment of the NRDL, China’s national reimbursement list.

“Emerging economies are beginning to understand how the pharmaceutical industry can drive cost containment in health care. 2010 brings great uncertainty and knowing not just what these governments are saying but what they mean and how they intend to respond to cost pressures is critical to formulating viable strategies for success in these promising markets."

To learn more, please contact Cyrus Chowdhury, Vice President, Global Market Access at cyrus.chowdhury@insightstrat.com

The Global Market Access practice at Insight Strategy Advisors provides pharmaceutical and biotechnology companies advisory services for maximizing market access across the global marketplace. Engagements include, but are not limited to, pricing and market access assessments, portfolio optimization strategies, and partnership due diligence. ISA has a global network of market experts who advise on all global engagements as well as an experienced multinational team of consultants and project managers headquartered in New York City and Geneva.